echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ESC-Lancet: Beware of 19 autoimmune diseases, the risk of comorbid cardiovascular disease is too high!

    ESC-Lancet: Beware of 19 autoimmune diseases, the risk of comorbid cardiovascular disease is too high!

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ▎Edited by WuXi AppTec Content Team


    Some autoimmune diseases are considered to be associated with an increased risk of cardiovascular disease.


    Screenshot source: the Lancet


    The study finally included 446,449 patients with autoimmune disease as a disease cohort, all of whom were newly diagnosed with autoimmune disease from 2000 to 2017, and did not have cardiovascular disease within 1 year after diagnosis, and included 2102830 The general population served as the matching cohort


     

    ▲Figure 1: 19 common autoimmune diseases and 12 cardiovascular diseases 


    Autoimmune disease patients are more likely to develop cardiovascular disease



    The incidence of cardiovascular disease in patients with autoimmune diseases was 23.


     

    ▲Figure 2: The incidence and risk ratio of cardiovascular disease in patients with autoimmune disease and the general population by different subgroups (source of screenshot: Reference [1])


    Autoimmune diseases were significantly associated with risk regardless of cardiovascular disease, with the highest associations being myocarditis, pericarditis, peripheral artery disease, and infective endocarditis


     

    ▲Figure 3: Cumulative incidence of cardiovascular disease in patients with autoimmune diseases and the general population (source of screenshot: Reference [1])


    The higher the number of autoimmune diseases, the higher the risk of cardiovascular disease


    The higher the number of autoimmune diseases, the higher the risk of cardiovascular disease.



    Among the 19 autoimmune diseases, systemic sclerosis (HR=3·.


     

    ▲Figure 3: After stratification by the number of autoimmune diseases, the risk ratio of cardiovascular disease in patients with autoimmune diseases and the general population (source of screenshot: Reference [1])


    Dr Nathalie Conrad, author of the paper, from the Faculty of Public Health and Primary Care, KU Leuven, Belgium, said: "Patients with autoimmune diseases have a similar cardiovascular risk to those with type 2 diabetes, and there are specific interventions for type 2 diabetes.
    , but management for patients with autoimmune diseases is almost absent
    .

    Dr.
    Nathalie Conrad hopes that through this study, patients with autoimmune diseases and medical workers will realize the importance of preventing cardiovascular disease
    .

    But knowing the truth, and even more so, the next step is to understand why patients with autoimmune diseases are more likely to suffer from cardiovascular disease than ordinary people, and how to take effective preventive measures
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.